Group ACYW135 meningococcal polysaccharide vaccine (Chengdu Kanghua Biological)

ACYW135群脑膜炎球菌多糖疫苗（成都康华）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGroup ACYW135 meningococcal polysaccharide vaccine (Chengdu Kanghua Biological)
Drug Alias Name迈可信
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Development/production technology > Inactivated vaccine > Split vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitis, Meningococcal
Global Approved IndicationsMeningitis, Meningococcal
Approved Indications in ChinaMeningitis, Meningococcal
Original Approved Country/TerritoryMainland China
Original Approved Date2010/06/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDeyang Huakang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Kanghua Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeJ07AH04
Related LinksWikipedia